Robert Kornberg is a Cardiology physician affiliated with Mount Sinai Hospital. OpenAlex indexes 31 publications with 218 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
425 W 59th St
9c
New York, NY 100198022
Telephone
212-492-5550Registry record last updated 24 Apr 2019.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20257 payments
- BridgeBio Pharma, Inc.Program year20258 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.6%Beta blocker22.4%Metoprolol Succinate70%Carvedilol25%Metoprolol Tartrate3%Bisoprolol Fumarate2%Part D<11 patientsStatin16.2%Atorvastatin Calcium84%Rosuvastatin Calcium16%Part D≥133 patients+ 13 more classes in this area
Blood & clotting
10%Factor Xa inhibitor6.6%Eliquis80%Xarelto20%Part D≥53 patientsP2Y12 inhibitor3.4%Clopidogrel89%Brilinta11%Part D<11 patientsMetabolism & gastrointestinal
6.3%SGLT2 inhibitor5.1%Jardiance81%Farxiga19%Part D<11 patientsPotassium supplement0.9%Potassium Chloride100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 100.02 STEMI Care Coordination Platform Health System Expansion
JACC: Cardiovascular Interventions
2026 - Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial
Circulation Cardiovascular Quality and Outcomes
2025 - Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial
Journal of the American Heart Association
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Allison McGeer
Mount Sinai Hospital
Scott Sicherer, MD
Mount Sinai Hospital
Ulrich Specks
Mount Sinai Hospital
Jorge Sánchez‐Guerrero
Mount Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”